Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Trimi vs California Trim Clinic

Two GLP-1 desks, one scoreboard. We put Trimi and California Trim Clinic head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 2 · Grade B+

Trimi

Visit Trimi Full brief →
vs
No. 490 · Grade C

California Trim Clinic

Visit California Trim Clinic Full brief →

The verdict

Trimi takes this head-to-head.

Trimi scores 89 to 45 on our six-factor Brief Score — A clean, all-in membership desk that publishes one price on both molecules nationwide and hasn't played the teaser-rate game.

That doesn't make California Trim Clinic a bad call — it's best for readers who want women in perimenopause seeking compounded glp-1 microdosing via 100% virtual telehealth. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
90
28
Supply Reliability
89
67
Transparency
91
20
Access Breadth
89
30
Clinical Oversight
88
76
Track Record
84
60
TrimiBrief Score 89 · 45California Trim Clinic

Price, coverage & the tracker

TrimiCalifornia Trim Clinic
Brief Score89/100 (B+)45/100 (C)
Semaglutide$196/moNot disclosed
Tirzepatide$296/moNot disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

Trimi: Membership rate held flat this cycle — both molecules disclosed up front, no first-month teaser.

California Trim Clinic: New to the tracker on 1 August 2026. This program publishes no monthly medication price, so there is no line for us to track until it does.

Not sold on either?

CoreAge Rx tops the whole board at 94/100.

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.